Back to today’s briefing

Story perspectives

Weight Loss Drugs: Users Regain 66% of Lost Weight

2/18/2025

27 3

Summary

Story summary

GLP-1 agonists, such as Semaglutide, are gaining traction for weight loss, yet many users face the disheartening reality of regaining two-thirds of their lost weight within a year after stopping the medication. With high costs and possible long-term health risks looming, experts advocate for tackling the root health issues rather than depending solely on these drugs.

1 of 1

Story summary

GLP-1 agonists, such as Semaglutide, are gaining traction for weight loss, yet many users face the disheartening reality of regaining two-thirds of their lost weight within a year after stopping the medication. With high costs and possible long-term health risks looming, experts advocate for tackling the root health issues rather than depending solely on these drugs.